Pelvic Floor Stimulation as a Treatment of Urinary and Fecal Incontinence
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - Rhode Island policy alerts
Know when Blue Cross Blue Shield - Rhode Island releases new policies or updates existing guidance.
Monitor payer policy activity
Defines coverage stance for non‑implantable pelvic floor electrical and magnetic stimulation as treatments for urinary and fecal incontinence for BCBSRI members, with distinctions between Medicare Advantage and Commercial products.
No material clinical or coverage changes in this revision.
Coverage Criteria
Medicare Advantage — Electrical PFS for Urinary Incontinence
Coverage for Medicare Advantage members
Coverage aligned with Medicare National Coverage Determination; stimulation typically delivered by vaginal or anal probes connected to an external pulse generator.
Not Covered — Magnetic PFS and Fecal Incontinence
Noncoverage due to insufficient evidence
Applies to listed modalities and indications
Commercial Products — Not Covered
Commercial product exclusions
Benefits may vary by contract; refer to Evidence of Coverage
This policy distinguishes coverage by product line. Commercial products exclude pelvic floor electrical or magnetic stimulation using a non-implantable stimulator for both urinary and fecal incontinence; such services are considered a contract exclusion and are not covered under Commercial plans.
Coverage and payment are governed by the member's subscriber agreement or employer agreement; those documents supersede this medical policy. Providers must verify member-specific benefits and eligibility with the provider call center. If services are determined to be not medically necessary or non-covered benefits, the member may be financially responsible unless they provided informed written consent in advance to receive and pay for the service.
Systematic reviews and randomized controlled trials (RCTs) have not demonstrated consistent, significant benefits for pelvic floor stimulation across indications. For urinary incontinence, systematic reviews of RCTs did not find that electrical PFS consistently improves net health outcomes versus placebo or conservative treatments, and evidence for magnetic PFS is limited by small trials, short follow-up, methodological limitations, and heterogeneity. For fecal incontinence, RCTs and systematic reviews have not shown electrical PFS to be superior to control interventions, and there are no RCTs for magnetic PFS. Overall, the evidence is insufficient to determine effects on health outcomes for these modalities and indications.
Coding
| 53899 | Unlisted procedure, urinary system (to be used for pulsed magnetic stimulation for the treatment of incontinence) |
| E0740 | Nonimplanted pelvic floor electrical stimulator, complete system |
| E0740 | Nonimplanted pelvic floor electrical stimulator, complete system |
Provider Actions & Requirements
Coding and prior authorization
Prior authorization is not required for pelvic floor stimulation services under this policy. Use CPT 53899 (Unlisted procedure, urinary system) for pulsed magnetic stimulation and HCPCS E0740 (Nonimplanted pelvic floor electrical stimulator, complete system) for non‑implanted electrical stimulators (E0740 covered for Medicare Advantage only).
Check member benefits and prior authorization
Verify member-specific benefits and prior authorization requirements with the plan before scheduling services; coverage and eligibility are governed by the member’s subscriber agreement or employer agreement and may differ by product. Contact the provider call center for member‑specific information.
Require documented failed PME trial before electrical PFS
For Medicare Advantage members, a documented failed trial of pelvic muscle exercise (PME) training is required before electrical PFS is covered. A failed trial is defined as no clinically significant improvement after completing 4 weeks of an ordered PME plan.
- PME trial duration: 4 weeks
- Failure definition: no clinically significant improvement in urinary continence after the PME trial
Document clinical indication and cognitive status for Medicare Advantage
For Medicare Advantage coverage, ensure the patient is cognitively intact and documentation demonstrates prior PME failure as specified; include clinical rationale linking electrical PFS to treatment of stress and/or urge urinary incontinence.
- Document cognitive status (patient must be cognitively intact)
- Document indication: stress and/or urge urinary incontinence
- Document prior PME trial and outcome
Required clinical documentation for Medicare Advantage
When requesting Medicare Advantage coverage, include documentation that the patient is cognitively intact and has failed a documented 4‑week trial of pelvic muscle exercise training (PME) per the Medicare NCD criteria.
- State that non‑implantable electrical stimulator is being used for stress and/or urge urinary incontinence
- Include PME trial details and outcome
- Include device code HCPCS E0740 if applicable
Confirm benefits and obtain informed consent for non‑covered services
Verify member eligibility and benefits with the provider call center prior to providing non‑covered services; if the member agrees to pay for a non‑covered service, obtain documented informed written consent in advance.
- Confirm benefits/eligibility via provider call center
- Obtain advance written consent if the member will self‑pay for non‑covered services
Commercial product exclusion — do not bill as covered
Do not bill commercial products for pelvic floor electrical or magnetic stimulation with a non‑implantable stimulator as these are contract exclusions and are not covered for Commercial products.
- Commercial coverage stance: pelvic floor electrical or magnetic stimulation with a non‑implantable stimulator is a contract exclusion
- Do not expect payment from Commercial plans for these services unless contractually specified
Noncoverage triggers that may lead to claim denial
Claims for magnetic pelvic floor stimulation or any PFS for fecal incontinence for Medicare Advantage members may be denied because evidence is insufficient to support these indications; do not expect coverage for magnetic PFS or PFS for fecal incontinence.
- Magnetic PFS for urinary incontinence (Medicare Advantage) is not covered
- Electrical or magnetic PFS for fecal incontinence (all products) is not covered
Benefit and medical necessity limitations — potential for member liability
Coverage and payment depend on the member’s subscriber agreement or employer agreement; services determined to be not medically necessary or non‑covered may result in denial or member financial responsibility unless the member agreed in writing in advance.
- Benefits and eligibility supersede policy provisions
- Providers may not charge members for non‑covered services unless written agreement obtained in advance
Background
Pelvic floor stimulation (PFS) is a nonsurgical treatment that uses either electrical stimulation delivered via vaginal or rectal probes or extracorporeal magnetic stimulation delivered through a chair with an embedded magnet to stimulate pelvic floor muscles or the pudendal nerve. The proposed mechanisms include improving urethral closure, augmenting periurethral muscle strength, and promoting reinnervation; methods vary by electrode location, stimulus frequency/intensity, treatment schedule, and whether treatment is administered in clinic or at home.
Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.